RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Talecris Biotherapeutics, Inc. (http://www.talecris.com) announced today their Talents program is now accepting applications for 2007 research awards. Talents, or Talecris New Trials Support (http://www.talecristalents.com), is designed to advance basic and clinical research addressing the use of intravenous immunoglobulin (IGIV) in antibody replacement as well as immune modulation therapies. Talents research grants total approximately $1 million annually and provide an important source of funding for research scientists investigating the cause and treatment of immune disorders.
